We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Empowering landlords with the tools they need to efficiently manage the letting process of their properties. Honest Homes aims to cut out intermediaries and instead offers transparent systematic guides via their online platform to save UK landlords and tenants time and money. Their service provides users with abilities to create contracts, ensure compliance and perform monetary transactions for the collection and payment of deposits and rent. Honest Homes' all-in-one solution aims to reduce average landlord admin costs from 12%, to 3%. Their service is designed to be fully automated and includes features such as reviews and ratings for both landlords and tenants. The company is aiming to host 1.8% of UK addresses by their fifth year, which represents around 60k listings and they are also planning to expand their services into Europe.
days to go: Expired investment: £166,670
My Friends Room allows travellers to rent accommodation from friends and friends of friends. Many vacation rentals can seem unsafe and impersonal. However renting from a friend or someone that has been recommended from a friend prevents this feeling of unsafety.
days to go: Expired investment: £97,870
Trecento Diagnostics, with the help of a molecular testing system complete, they are now ready to launch a patent-pending collection device named HygieCatch®. It is a non-invasive, needle-free examination, in the vet practice providing DNA extraction from urine onsite with a report within 40 minutes of extraction of the sample. The company has identified partners in the UAE and US and is also in early-stage discussions with UK vet practices.  Furthermore, for the purpose of commercialisation of HygieCatch & the technology used, alongside addition of new tests including Lyme disease the company is planning to raise its capital.  
days to go: Expired investment: £167,910
Ofixu is an online platform that ai mto help you with your office requirements. If you have underutilised space then Ofixu will help you earn extra cash by listing it at no extra cost. On the other hand, if you're an entrepreneur looking to rent an office, you can find one local to you by using Ofixu's worldwide search function. 
days to go: Expired investment: £52,412
Ofixu is an online platform that aim to help you with your office requirements. If you have underutilised space then Ofixu will help you earn extra cash by listing it at no extra cost. On the other hand, if you're an entrepreneur looking to rent an office, you can find one local to you by using Ofixu's worldwide search function.
days to go: Expired investment: £151,762
Tourniglo is a company that has come up with a unique two in one emergency tourniquet with a built-in torch. The innovation was driven by an identified need within the emergency services to provide an immediately available light source in dim-lighted areas when undertaking a patient or casualty eye examination as well as for military and close protection staff who might need to inject intravenous medication in rural areas. The global tourniquet systems market is expected to reach half a billion US dollars by 2025. The company aims to launch the production of its first product. Additionally, Tourniglo has been featured on the BBC website and has won various medals at international events, including a 'Gold Medal' at the World Invention Awards. The company requires investment to set-up manufacturing, packaging and distribution, and grow sales for the first year of commercialisation.
days to go: Expired investment: £21,414
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £270,543
Housebooker offers holiday accommodation in real peoples homes. They provide its clients with a way of generating a significant income through their managed services and aim to achieve a better return for their clients over what they would traditionally get from a buy-to-let. 
days to go: Expired investment: £12,950
HouseStars is a comprehensive property maintenance application powered by AI, enabling convenient connections between property owners and various trade professionals, such as builders, plumbers, electricians, and gas engineers. With this app, property upkeep is simplified - you can choose a service provider based on their ratings, select a suitable date and time, engage in communication, leave reviews, and complete secure payments through an escrow system, all through your mobile device.
days to go: Expired investment: £162,203
Propnology is a crowdfunding platform specifically designed for property. Founded in 2014, their aim is to encourage a more diverse group of individuals to invest. Propnology allows users to invest in property from as little as £500. 
days to go: Expired investment: £57,209
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph